ClinicalTrials.gg
RecruitingNCT03874416REHAB-MDTUpdated Sep 6, 2023

Cognitive Rehabilitation of Working Memory After Moderate to Severe Traumatic Brain Injury

An interventional study of Specific rehabilitation and Non-specific rehabilitation in Moderate to Severe Traumatic Brain Injury, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 1 site in France. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-09-06.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 7 months ago, but the record still lists the study as recruiting.
  • Started Jan 2021; still recruiting 5 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Brain Injuries, Traumatic by Assistance Publique - Hôpitaux de Paris — 6 open to participants now, 7 under way, none of them phase 3. Brain Injuries, Traumatic · Assistance Publique - Hôpitaux de Paris.

Started
2021
with 2 others
No phase
6 of 15
1 open now
Registered
4th of 15
by date

Among the 15 studies in Brain Injuries, Traumatic by Assistance Publique - Hôpitaux de Paris, this one is one of 3 that started in 2021, is one of 6 with no phase, and was the 4th registered.

Brain Injuries, Traumatic

1,725 studies on the registry are indexed under Brain Injuries, Traumatic; 450 are open to participants now.

Browse Brain Injuries, Traumatic studies →

Open to participants now

6 of the 15 studies in Brain Injuries, Traumatic by Assistance Publique - Hôpitaux de Paris are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 287 Brain Injuries, Traumatic studies recruiting now, 126 (44%) set no upper age limit and 119 (41%) stop at 75 or younger; 41 take children under 18; 53 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Brain Injuries, Traumatic by Assistance Publique - Hôpitaux de Paris, or all of them as a file.
02

Study summary

The study aims to demonstrate improvement of daily life functioning and improvement of cognitive tests in post traumatic brain injury (TBI) patients suffering from working memory deficit, by a 3-month specific cognitive rehabilitation program, in comparison with patients with usual non-specific rehabilitation of same duration.

As secondary objectives, the study aims to:

  • demonstrate improvement of specific neuropsychological tests of working memory;
  • demonstrate improvement of non-specific tasks involving working memory;
  • assess the evolution in not-targeted domains by the specific rehabilitation, which would give evidence of a global cognitive stimulation effect;
  • demonstrate improvement of social integration ability and quality of life;
  • demonstrate persistence of effects at 3 months and 6 months after the end of treatment;
  • demonstrate the acceptability, the tolerance and the feasibility of rehabilitation.
Read the detailed description

Working memory is an essential cognitive function which allows to store briefly and treat simultaneous informations, but is often altered after a moderate to severe TBI. This alteration results in disabilities and social integration difficulties in the post TBI patients. The study team had developped a standardized and hierarchized rehabilitation program of working memory. Several experiments have shown the efficacy of the program which is now used in routine care by speech-language pathologists and neuropsychologists. However it is necessary to provide a robust demonstration of its efficacy in improving function in daily life.

This randomized multicenter study will be performed in 6 centers in the area of Île-de-France. 54 patients will be randomized 1:1 to receive either specific rehabilitation of working memory or non-specific rehabilitation. A 10-month follow-up is planned for patients of the two arms.

03

Conditions studied

  • Moderate to Severe Traumatic Brain Injury

Keywords

  • moderate to severe traumatic brain injury
  • cognitive rehabilitation
  • working memory
  • daily life function
  • Working Memory Questionnaire, WMQ
  • Brown-Peterson test
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged between 18 - 65 years;
  • Moderate to severe TBI (Glasgow score between 3 and 12 in the 24 first hours);
  • At least 6 months following TBI;
  • Complaint related to working memory in daily life (scale > 29 of questionnaire of complaint on working memory (WMQ), and established deficit of working memory by one of the following criteria:

    1. Index of working memory (IWM) of Wechsler Adult Intelligence Scale (WAIS-IV) \< 85 or p \< .05 between IWM and one of the WAIS-IV index;
    2. Less than 70% correct responses on Brown-Peterson tasks test in the verbal modality with an interfering task as mental calculation;
    3. Less than 89% correct responses on Brown-Peterson tasks test in the verbal modality with an interfering task of articulatory suppression;
    4. Less than 70% correct responses on Brown-Peterson tasks test in the visuospatial modality with an interfering motor task.
  • Prior medical examination;
  • Correct vision after visual acuity correction;
  • Stable neurological or psychoactive treatment for at least 4 weeks, if applicable;
  • Able to move to the center where rehabilitation will be performed;
  • Covered by a health insurance;
  • Signed consent of patient or of the guardian.

Exclusion criteria

Exclusion Criteria:

  • History of central nervous system disorder, or history of psychological disorder or substance abuse;
  • Prior specific cognitive rehabilitation of working memory;
  • Instrumental activities disabilities, cognitive disorder, behavioural disorders or major psychiatric disorder;
  • Major anxio-depressive syndrome or present psychiatric disorder which can interfere with experimental procedure or measured variables;
  • Pregnant or breastfeeding woman.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
54 participants (estimated)

Study arms

  • Experimental
    Specific rehabilitation of working memory

    Specific rehabilitation of working memory according to hierarchized rehabilitation.

    Other: Specific rehabilitation

  • Active comparator
    Control group

    Non-specific rehabilitation of working memory, usual therapy.

    Other: Non-specific rehabilitation

Interventions

  • OtherSpecific rehabilitation

    Experimental rehabilitation of working memory: 3 sessions per week during 3 months, for a total 36 sessions.

  • OtherNon-specific rehabilitation

    Usual non-specific rehabilitation treatment for moderate to severe TBI in healthcare facilities: 2-3 sessions per week for 3 months.

06

What researchers measure

Primary outcomes

  1. Proportions of simultaneous responders

    A patient will be considered as a responder if he improves simultaneously on the Working Memory Questionnaire (WMQ) and the Brown-Peterson Task. Proportions will be calculated of patients simultaneously improving on the Working Memory Questionnaire (WMQ) and the Brown-Peterson Task: * increase of at least 12 points on WMQ scale, * at least 13% score improvement on the verbal or visuo-spatial Brown-Peterson Task.

    Time frame: 3 months after the first rehabilitation session

Secondary outcomes

  1. Working Memory Questionnaire during rehabilitation program

    The Working Memory Questionnaire (WMQ), an auto-questionnaire elaborated by the study team, will be used. The WMQ is a self-administered scale, addressing three dimensions of working memory: short-term storage, attention, and executive control. It is a self-assessment questionnaire comprising 30 questions scored on a five-point Likert scale, ranging from 0 ("no problem at all") to 4 ("very severe problem in everyday life"). The total score will be used.

    Time frame: At baseline, 3 months, 6 months and 9 months

  2. Cognitive task of working memory

    Working memory span tasks

    Time frame: At baseline, 3 months, 6 months and 9 months

  3. Cognitive task of working memory

    Verbal and visuospatial working memory.

    Time frame: At baseline, 3 months, 6 months and 9 months

  4. Cognitive task of working memory

    n-back task

    Time frame: At baseline, 3 months, 6 months and 9 months

  5. Cognitive task of working memory

    Brown-Peterson Visual.

    Time frame: At baseline, 3 months, 6 months and 9 months

  6. Cognitive task of working memory

    reading span task.

    Time frame: At baseline, 3 months, 6 months and 9 months

  7. Cognitive task of working memory

    Working Memory Index (WISC-IV).

    Time frame: At baseline, 3 months, 6 months and 9 months

  8. Cognitive task of working memory

    divided attention task

    Time frame: At baseline, 3 months, 6 months and 9 months

  9. Arithmetic resolution

    Non-specific tasks involving working memory: arithmetic resolution ability by WAIS index

    Time frame: At baseline, 3 months and 6 months

  10. Non-targeted cognitive measurements

    Executive functions will be assessed.

    Time frame: At baseline, 3 months and 6 months

  11. Non-targeted cognitive measurements

    Long-term memory will be assessed.

    Time frame: At baseline, 3 months and 6 months

  12. Non-targeted cognitive measurements

    The speed of treatment will be assessed.

    Time frame: At baseline, 3 months and 6 months

  13. Social functioning assessement

    Assessed by Manual for Sydney Psychosocial Reintegration Scale (SPRS)

    Time frame: At baseline, 3 months, 6 months and 9 months

  14. Quality of life assessment

    Assessed by Qolibri scale

    Time frame: At baseline, 3 months, 6 months and 9 months

  15. Quality of life assessment

    Assessed by EQ5D-5

    Time frame: At baseline, 3 months, 6 months and 9 months

  16. Acceptability

    Compliance of rehabilitation program: duration of training of speech-language pathologist and psychologist to the rehabilitation program.

    Time frame: At baseline, 3 months and 6 months

  17. Acceptability

    Compliance of rehabilitation program: duration of session.

    Time frame: At baseline, 3 months and 6 months

  18. Acceptability

    Compliance of rehabilitation program: patient's satisfaction of care (Client Satisfaction Questionnaire (CSQ-8)).

    Time frame: At baseline, 3 months and 6 months

  19. Acceptability

    Compliance of rehabilitation program: presence during rehabilitation session of working memory.

    Time frame: At baseline, 3 months and 6 months

07

Study locations

1 of 1 sites recruiting
  • Physical medicine and rehabilitation department, Raymond Poincaré Hospital
    Garches, Hauts-de-seine 92380, France
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2021 (actual). Primary completion is estimated for Apr 2025, 51 months after the start.

Of 445 non-industry interventional studies with no phase under Brain Injuries, Traumatic, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 64. This study's planned 51 months is above that.

Counting every sponsor, half of 467 studies reached it within 41 months; a quarter within 22 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 4, 2019
First posted
Mar 14, 2019
StartActual
Jan 25, 2021
Primary completionEst.
Apr 2025
CompletionEst.
Apr 2025
Last update
Sep 6, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03874416
Responsible party
Sponsor
First posted
Mar 14, 2019
Start date
Jan 25, 2021
Primary completion
Apr 2025 (estimated)
Completion
Apr 2025 (estimated)
Last update
Sep 6, 2023

Study contacts

Claire Vallat-Azouvi, PhD
Contact
claire.vallat-azouvi@univ-paris8.fr
+33 1 47 10 76 47
Philippe Azouvi, MD, PhD
Contact
philippe.azouvi@aphp.fr
+33 1 47 10 70 78
Claire Vallat-Azouvi, PhD
principal investigator · Laboratoire LPN, EA2027-Université Paris 8, and Hôpital Raymond Poicaré-Antenne UEROS-UGECAMIDF
Philippe Azouvi, MD, PhD
study director · Service Médecine Physique et de Réadaptation, Hôpital Raymond Poicaré, 92380 Garches

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion